1921
Volume 99, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Pulmonary tuberculosis (PTB) is associated with modulation of levels of adipokines, specifically adiponectin and leptin, but the effect of standard antituberculosis treatment (ATT) on the systemic levels of adiponectin, resistin, and leptin has not been well explored. To identify the association of adipokines with PTB and their relationship with disease severity and bacterial burden, we measured the levels of adiponectin, resistin, and leptin in PTB individuals and compared them with latent tuberculosis (LTB) and healthy control (HC) individuals. Pulmonary tuberculosis was characterized by diminished circulating levels of adiponectin and leptin and heightened circulating levels of resistin in comparison to that in LTB and HC individuals. However, PTB with bilateral or cavitary disease did not exhibit any increased systemic levels of these adipokines in comparison with those with unilateral or non-cavitary disease, respectively. In addition, none of the adipokines exhibited a positive correlation with bacterial burdens, but adiponectin alone exhibited a negative correlation with body mass index in PTB individuals. Finally, on successful completion of ATT, PTB individuals exhibited significantly increased levels of adiponectin and leptin and significantly decreased levels of resistin. Therefore, our data identify an important association of systemic adipokine levels with PTB disease and its alteration following ATT.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0206
2018-09-04
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/4/tpmd180206.html?itemId=/content/journals/10.4269/ajtmh.18-0206&mimeType=html&fmt=ahah

References

  1. Tilg H, Moschen AR, , 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772783. [Google Scholar]
  2. Wellen KE, Hotamisligil GS, , 2005. Inflammation, stress, and diabetes. J Clin Invest 115: 11111119. [Google Scholar]
  3. Calle EE, Kaaks R, , 2004. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579591. [Google Scholar]
  4. La Cava A, Matarese G, , 2004. The weight of leptin in immunity. Nat Rev Immunol 4: 371379. [Google Scholar]
  5. Kusminski CM, McTernan PG, Kumar S, , 2005. Role of resistin in obesity, insulin resistance and type II diabetes. Clin Sci (Lond) 109: 243256. [Google Scholar]
  6. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW, Jr., 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116: 115124. [Google Scholar]
  7. Shehzad A, Iqbal W, Shehzad O, Lee YS, , 2012. Adiponectin: regulation of its production and its role in human diseases. Hormones (Athens) 11: 820. [Google Scholar]
  8. Cheng X, Folco EJ, Shimizu K, Libby P, , 2012. Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells. J Biol Chem 287: 3689636904. [Google Scholar]
  9. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A, , 2005. Resistin, an adipokine with potent proinflammatory properties. J Immunol 174: 57895795. [Google Scholar]
  10. Wiedmer P, Nogueiras R, Broglio F, D’Alessio D, Tschop MH, , 2007. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 3: 705712. [Google Scholar]
  11. Leite-Moreira AF, Soares JB, , 2007. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today 12: 276288. [Google Scholar]
  12. Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C, Sanchez-Margalet V, , 2010. Role of leptin in the activation of immune cells. Mediators Inflamm 2010: 568343. [Google Scholar]
  13. Kim JH, Lee CT, Yoon HI, Song J, Shin WG, Lee JH, , 2010. Relation of ghrelin, leptin and inflammatory markers to nutritional status in active pulmonary tuberculosis. Clin Nutr 29: 512518. [Google Scholar]
  14. van Crevel R, Karyadi E, Netea MG, Verhoef H, Nelwan RH, West CE, van der Meer JW, , 2002. Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation. J Clin Endocrinol Metab 87: 758763. [Google Scholar]
  15. Keicho N, Matsushita I, Tanaka T, Shimbo T, Hang NT, Sakurada S, Kobayashi N, Hijikata M, Thuong PH, Lien LT, , 2012. Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation. PLoS One 7: e38703. [Google Scholar]
  16. Ehtesham NZ, Nasiruddin M, Alvi A, Kumar BK, Ahmed N, Peri S, Murthy KJ, Hasnain SE, , 2011. Treatment end point determinants for pulmonary tuberculosis: human resistin as a surrogate biomarker. Tuberculosis (Edinb) 91: 293299. [Google Scholar]
  17. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V, , 2003. The Chennai Urban Rural Epidemiology Study (CURES)–study design and methodology (urban component) (CURES-I). J Assoc Physicians India 51: 863870. [Google Scholar]
  18. Makki K, Froguel P, Wolowczuk I, , 2013. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013: 139239. [Google Scholar]
  19. Tsang JY, Li D, Ho D, Peng J, Xu A, Lamb J, Chen Y, Tam PK, , 2011. Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int Immunopharmacol 11: 604609. [Google Scholar]
  20. Santucci N, D’Attilio L, Kovalevski L, Bozza V, Besedovsky H, del Rey A, Bay ML, Bottasso O, , 2011. A multifaceted analysis of immune-endocrine-metabolic alterations in patients with pulmonary tuberculosis. PLoS One 6: e26363. [Google Scholar]
  21. Chang SW, Pan WS, Lozano Beltran D, Oleyda Baldelomar L, Solano MA, Tuero I, Friedland JS, Torrico F, Gilman RH, , 2013. Gut hormones, appetite suppression and cachexia in patients with pulmonary TB. PLoS One 8: e54564. [Google Scholar]
  22. Pan L, 2017. Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection. Oncotarget 8: 112907112916. [Google Scholar]
  23. van Lettow M, van der Meer JW, West CE, van Crevel R, Semba RD, , 2005. Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi. J Clin Endocrinol Metab 90: 47714776. [Google Scholar]
  24. Yurt S, Erman H, Korkmaz GG, Kosar AF, Uysal P, Gelisgen R, Simsek G, Uzun H, , 2013. The role of feed regulating peptides on weight loss in patients with pulmonary tuberculosis. Clin Biochem 46: 4044. [Google Scholar]
  25. Wieland CW, Florquin S, Chan ED, Leemans JC, Weijer S, Verbon A, Fantuzzi G, van der Poll T, , 2005. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol 17: 13991408. [Google Scholar]
  26. Perna V, Perez-Perez A, Fernandez-Riejos P, Polo-Padillo J, Batista N, Dominguez-Castellano A, Sanchez-Margalet V, , 2013. Effective treatment of pulmonary tuberculosis restores plasma leptin levels. Eur Cytokine Netw 24: 157161. [Google Scholar]
  27. Yuksel I, Sencan M, Dokmetas HS, Dokmetas I, Ataseven H, Yonem O, , 2003. The relation between serum leptin levels and body fat mass in patients with active lung tuberculosis. Endocr Res 29: 257264. [Google Scholar]
  28. Mexitalia M, Dewi YO, Pramono A, Anam MS, , 2017. Effect of tuberculosis treatment on leptin levels, weight gain, and percentage body fat in Indonesian children. Korean J Pediatr 60: 118123. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0206
Loading
/content/journals/10.4269/ajtmh.18-0206
Loading

Data & Media loading...

  • Received : 09 Mar 2018
  • Accepted : 19 Jul 2018
  • Published online : 04 Sep 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error